L-DOPA AND SCHIZOPHRENIA

被引：7
作者：
GARFINKEL, PE
STANCER, HC
机构：
[1] CLARKE INST PSYCHIAT,TORONTO,ONTARIO,CANADA
[2] UNIV TORONTO,TORONTO,ONTARIO,CANADA
来源：
CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL | 1976年 / 21卷 / 01期
关键词：
D O I：
10.1177/070674377602100105
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：27 / 29
页数：3
相关论文
共 50 条
  • [41] L-DOPA IN PARKINSONISM
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1969, 2 (5651): : 202 - +
  • [42] L-dopa Allergy
    Gatto, Emilia
    Cesarini, Martin
    Luis Etcheverry, Jose
    Da Prat, Gustavo
    Gonzalez Rojas, Natalia
    Parisi, Virginia
    Persi, Gabriel
    Rojas, Galeno
    Aldinio, Victoria
    MOVEMENT DISORDERS, 2018, 33 : S80 - S80
  • [43] L-DOPA AND NARCOLEPSY
    FRIEDMAN, EH
    NEUROLOGY, 1992, 42 (08) : 1640 - 1641
  • [44] L-DOPA IN PARKINSONISM
    SPIERS, ASD
    BRITISH MEDICAL JOURNAL, 1969, 2 (5654) : 448 - &
  • [45] L-DOPA cyclohexyl ester is a novel potent and stable competitive antagonist against L-DOPA, as compared to L-DOPA methyl ester
    Misu, Y
    Furukawa, N
    Miyamae, T
    Goshima, Y
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R142 - R142
  • [46] ACTIVITY OF L-DOPA DECARBOXYLASE ON METAL L-DOPA CHELATE - INVITRO STUDIES
    RAJAN, KS
    WIEHLE, RD
    ROBINSON, M
    DAVIS, JM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1979, (APR): : 86 - 86
  • [47] EFFECT OF L-DOPA AND L-DOPA ANALOGS ON SIDMAN AVOIDANCE PERFORMANCE IN MICE
    THUT, PD
    PHARMACOLOGIST, 1974, 16 (02): : 307 - 307
  • [48] L-DOPA cyclohexyl ester is a novel stable and potent competitive antagonist against L-DOPA, as compared to L-DOPA methyl ester
    Misu, Y
    Goshima, Y
    Miyamae, T
    Furukawa, N
    Sugiyama, Y
    Okumura, Y
    Shimizu, M
    Ohshima, E
    Suzuki, F
    JAPANESE JOURNAL OF PHARMACOLOGY, 1997, 75 (03) : 307 - 309
  • [49] Insight into L-DOPA dioxygenase mechanism with 6-substituted L-DOPA derivatives
    Nyamkondiwa, Kudzai
    Squires, Trevor
    Jones, Paige
    Colabroy, Keri L.
    Peterson, Larryn W.
    FASEB JOURNAL, 2022, 36
  • [50] TREATMENT OF PARKINSONS DISEASE - COMPARISON OF L-DOPA AND A COMBINATION OF L-DOPA AND DECARBOXYLASE INHIBITOR
    GORLICH, J
    MARKUS, E
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1972, 97 (34) : 1246 - &
12345